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Abstract: Retrotransposons can alter the regulation of genes both transcriptionally and
post-transcriptionally, through mechanisms such as binding transcription factors and alternative
splicing of transcripts. SINE-VNTR-Alu (SVA) retrotransposons are the most recently evolved class
of retrotransposable elements, found solely in primates, including humans. SVAs are preferentially
found at genic, high GC loci, and have been termed “mobile CpG islands”. We hypothesise that
the ability of SVAs to mobilise, and their non-random distribution across the genome, may result
in differential regulation of certain pathways. We analysed SVA distribution patterns across the
human reference genome and identified over-representation of SVAs at zinc finger gene clusters. Zinc
finger proteins are able to bind to and repress SVA function through transcriptional and epigenetic
mechanisms, and the interplay between SVAs and zinc fingers has been proposed as a major feature of
genome evolution. We describe observations relating to the clustering patterns of both reference SVAs
and polymorphic SVA insertions at zinc finger gene loci, suggesting that the evolution of this network
may be ongoing in humans. Further, we propose a mechanism to direct future research and validation
efforts, in which the interplay between zinc fingers and their epigenetic modulation of SVAs may
regulate a network of zinc finger genes, with the potential for wider transcriptional consequences.
Keywords: retrotransposon; SVA; polymorphism; primate; zinc finger protein; ZNF; evolution
1. Introduction
Retrotransposons are known drivers of genetic diversity, with the ability to mobilise and insert new
copies of themselves into the genome, where they have the potential to regulate the expression of genes
at that loci by altering patterns of methylation, chromatin structure, transcription factor binding, or
gene splicing [1,2]. SINE-VNTR-Alus (SVAs) are the youngest and smallest family of retrotransposons
and are specific to hominids, with approximately 2700 elements in the human reference genome
(hg19) [3]. These elements are therefore of interest when investigating the most recent evolutionary
differences between humans and other primate species, or indeed within the human population. The
oldest of the seven human SVA subfamilies (SVAs A-F1), SVA A, is approximately 13.6 million years old,
with the younger SVA F subfamily being around 3.2 million years old [3]. SVA subfamilies A, B, and C
are found in multiple primate species, whereas the SVA E, F, and F1 subfamilies are human-specific.
SVA Ds are either human-specific or found in higher primate species including gorillas, bonobos, and
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common chimpanzees. In this study, we therefore considered SVA A, B, and C as the evolutionary
‘older’ grouping, while SVA D, E, F, and F1 were thought of as the more recent grouping.
Human-specific retrotransposon insertions are considered to be one of the two key driving forces
in the evolution of human-specific regulatory networks [4], with the second being recombination-based
exaptation of highly conserved segments of ancestral regulatory DNA. This evolution of more complex
gene regulatory mechanisms in higher primates and humans is likely to have in part impacted on
species- and tissue-specific gene regulation and allowed greater diversity with regard to epigenetic
modulation and response to environmental changes [5]. Work by Bennett et al. found that the average
person harboured 56 polymorphic SVAs in their genome [6], which would be expected to contribute
substantially to individual genetic variation. Bennett et al. also demonstrated that 79% of SVAs
in humans are missing from their equivalent genomic sites in the chimpanzee genome, suggesting
that SVAs have played a recent evolutionary role after the split between human and chimpanzee
species [6–9].
Many transposable element families are known to be distributed non-randomly across the human
genome. This was highlighted in the initial draft of the human genome, in which sections of the X
chromosome were found to contain extremely high densities of the LINE-1 retrotransposon sequence,
and Alu elements were found to be enriched on chromosome 19 [10]. The latter was predicted to be due
to the high gene and GC content of this chromosome. We and others have similarly demonstrated that
SVAs are not distributed randomly across the genome, with their distribution displaying preference for
regions of high GC content [3], particularly around genic regions, with 60% of SVA elements residing
either within genes or within 10 kb upstream [11]. This is consistent with reports from both Wang et al.
and Tang et al. that highlight chromosome 19 as a region of the genome particularly rich in SVAs [3,12],
with Grimwood et al. demonstrating that chromosome 19 has a higher proportion of transposable
element-derived sequence compared to the total genome (55% vs. 44.8%) [13].
We have previously demonstrated that SVA elements are over-represented in known Parkinson’s
disease gene loci [14], and are found at gene loci that modulate central nervous system (CNS)
pathways [15]. Previous studies have demonstrated the ability of SVA elements to modulate
gene expression both in vitro and in vivo, in human neuroblastoma cell lines and chick embryo
models [11,16–18], which would suggest that SVA elements have the potential to regulate gene
expression both through their regulatory characteristics and their location within the genome. Indeed,
Kim and Hahn have highlighted the ability of SVA insertions to act as novel promoters at their site of
integration, driving the expression of new, human-specific transcripts [7,8], with similar work by Kwon
et al. demonstrating the inclusion of SVA sequence in numerous human transcripts [9]. More recent
work by Tang et al. demonstrated that human-specific retrotransposon insertions have added 14.2 Mbp
to the human genome, contributing 84 kb of expressed human-specific transcripts [12]. In this analysis,
Tang et al. also found that 12.5% of human-specific SVAs overlapped with ENCODE ChIP-seq data,
suggesting that their presence within our genome has provided an additional 504 transcription factor
binding sites [12].
A canonical SVA is comprised of five main components, beginning with (a) a simple hexamer
repeat of (CCCTCT)n at the 5′ end, followed by (b) an Alu-like region made up of 2 antisense Alu
fragments separated by a region of intervening sequence, (c) a variable number tandem repeat (VNTR),
(d) a SINE region derived from the 3′ long terminal repeat (LTR) of the retroviral HERV-K10 element,
and finally (e) a 3′ poly(A) signal [3] (Figure 1). A typical full length SVA element is several thousand
bases in size, however, due to the young evolutionary age and the repetitive nature of the SVA structure,
many SVA elements are polymorphic in the human population both in their structure and in their
presence or absence. Structural polymorphism typically occurs within the (CCCTCT)n hexamer repeat,
the VNTR, and in the poly(A) region [11]. On the other hand, presence or absence polymorphisms
(known as retrotransposon insertion polymorphisms (RIPs)) refer to sites at which the presence of an
SVA is not yet fixed in the human population, and thus may be present at a particular locus in some
individuals but absent in others.
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Figure 1. Canonical SINE-VNTR-Alu (SVA) structure. Canonical SVAs typically contain five distinct 
regions; a (CCCTCT)n hexamer repeat at the 5′ end, an Alu-like domain, a variable number tandem 
repeat (VNTR), a SINE-derived region, and a poly(A) tail. The SVA F1 subfamily deviates from this 
typical structure as the (CCCTCT)n hexamer has been replaced by a 5′ transduction of the first exon 
of the MAST2 gene. While SVAs are approximately 2 kb in length, their size can vary due to changes 
in copy number in their repetitive domains. 
In the case of the seventh SVA subfamily, known as F1, this group lacks the 5′ (CCCTCT)n 
hexamer repeat, instead containing a 5′ transduction of exon 1 of the MAST2 gene [19]. SVA elements 
do not encode the necessary proteins for mobilisation, but rather co-opt the proteins encoded by 
LINE-1 retrotransposons for this purpose [20,21]. Mobilisation of SVAs is known to be repressed by 
zinc finger proteins of the KRAB family [22]. 
In this report, we have extended our previous study [15] by analysing the distribution of SVAs 
per megabase across the human reference genome, and separating this analysis by evolutionary age. 
This allowed us to identify patterns of SVA insertions across primate history, and to highlight 
possible gene networks whose regulation or expression may have been influenced by such changes 
in genomic structure through evolution. We find that SVAs are over-represented primarily at zinc 
finger gene clusters across multiple chromosomes. ZNF zinc fingers are the largest family of 
transcription factors in the human genome [23]. This gene family has a complicated evolutionary 
history due to multiple rounds of duplication between species, which has resulted in significant 
diversity, as well as their organisation in distinct gene clusters across the human genome [24–26]. 
Similar to SVAs, zinc finger genes have been found to be over-represented on chromosome 19, and 
their gene clusters are over-represented for other transposable elements, including endogenous 
retroviruses (ERVs) and long terminal repeat (LTR) retrotransposons [27,28]. This has led to the 
proposal of co-evolution between transposable elements and the zinc finger gene family [27,28], 
which we here extend to the SVA class of primate-specific transposable elements. 
2. Results 
2.1. SVAs Cluster at Specific Zinc Finger Loci, Particularly on Chromosome 19 
To begin understanding the distribution of SVAs across the human genome through 
evolutionary time, the reference genome SVA set (hg19; Supplementary File 1) was analysed both in 
total and as two separate sets, one containing the evolutionary older subfamilies, SVA A, B, and C, 
and the other containing the more recent subfamilies D, E, F, and F1 (Supplementary File 2). We have 
previously demonstrated that SVAs are increased around genic regions at the genomic scale [11]. 
Here, we found that the trend towards increased SVA number with higher transcript number held 
true for 22 of the 24 chromosomes to varying degrees (Supplementary File 3). However, chromosome 
19 and chromosome Y stood out clearly as the only chromosomes which deviated from this pattern, 
instead showing no correlation between SVA number and transcript number (correlation coefficients; 
Chr19 = −0.055 and ChrY = −0.140; Supplementary File 3). Since there are large regions of missing 
sequence data across Y chromosome on the UCSC Genome Browser, we were unable to determine 
whether this result was representative of the chromosome as a whole, and so did not continue further 
analysis. However, the lack of correlation on chromosome 19 appeared to be due to a small number 
of regions that were over-represented for SVAs in comparison to the number of transcripts at these 
regions (Figure 2a, red points). Overlaying the clustering patterns of the older SVA A, B, and C 
subfamilies with the more recent SVA D, E, F, and F1 subfamilies revealed that a four megabase 
Figure 1. Canonical SINE-VNTR-Alu (SVA) structure. Canonical SVAs typically contain five distinct
regions; a (CCCTCT)n hexamer repeat at the 5′ end, an Alu-like domain, a variable number tandem
repeat (VNTR), a SINE-derived region, and a poly(A) tail. The SVA F1 subfamily deviates from this
typical structure as the (CCCTCT)n hexamer has been replaced by a 5′ transduction of the first exon of
the MAST2 gene. While SVAs are approximately 2 kb in length, their size can vary due to changes in
copy number in their repetitive domains.
In the case of the seventh SVA subfamily, known as F1, this group lacks the 5′ (CCCTCT)n hexamer
repeat, instead containing a 5′ transduction of exon 1 of the MAST2 gene [19]. SVA elements do not
encode the necessary proteins for mobilisation, but rather co-opt the proteins encoded by LINE-1
retrotransposons for this purpose [20,21]. Mobilisation of SVAs is known to be repressed by zinc finger
proteins of the KRAB family [22].
In this report, we have extended our previous study [15] by analysing the distribution of SVAs
per megabase across the human reference genome, and separating this analysis by evolutionary
age. This allowed us to identify patterns of SVA insertions across primate history, and to highlight
possible gene networks whose regulation or expression may have been influenced by such changes in
genomic structure through evolution. We find that SVAs are over-represented primarily at zinc finger
gene clusters across multiple chromosomes. ZNF zinc fingers are the largest family of transcription
factors in the human genome [23]. This gene family has a complicated evolutionary history due to
multiple rounds of duplication between species, which has resulted in significant diversity, as well as
their organisation in distinct gene clusters across the human genome [24–26]. Similar to SVAs, zinc
finger genes have been found to be over-represented on chromosome 19, and their gene clusters are
over-represented for other transposable elements, including endogenous retroviruses (ERVs) and long
terminal repeat (LTR) retrotransposons [27,28]. This has led to the proposal of co-evolution between
transposable elements and the zinc finger gene family [27,28], which we here extend to the SVA class
of primate-specific transposable elements.
2. Results
2.1. SVAs Cluster at Specific Zinc Finger Loci, Particularly on Chromosome 19
To begin understanding the distribution of SVAs across the human genome through evolutionary
time, the reference genome SVA set (hg19; Supplementary File 1) was analysed both in total and as
two separate sets, one containing the evolutionary older subfamilies, SVA A, B, and C, and the other
containing the more recent subfamilies D, E, F, and F1 (Supplementary File 2). We have previously
demonstrated that SVAs are increased around genic regions at the genomic scale [11]. Here, we
found that the trend towards increased SVA number with higher transcript number held true for
22 of the 24 chromosomes to varying degrees (Supplementary File 3). However, chromosome 19
and chromosome Y stood out clearly as the only chromoso es which deviated from this pattern,
instead showing no correlation between SVA number and transcript number (correlation coefficients;
Chr19 = −0.055 and ChrY = −0.140; Supplementary File 3). Since there are large regions of missing
sequence data across Y chromosome on the UCSC Genome Browser, we were unable to determine
whether this result was representative of the chromosome as a whole, and so did not continue further
analysis. However, the lack of correlation on chromosome 19 appeared to be due to a small number
of regions that were over-represented for SVAs in comparison to the number of transcripts at these
regions (Figure 2a, red points). Overlaying the clustering patterns of the older SVA A, B, and C
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subfamilies with the more recent SVA D, E, F, and F1 subfamilies revealed that a four megabase stretch
at Chr19:20,000,000–24,000,000 was the primary source of the lack of correlation seen between SVA
number and transcript number on chromosome 19, and also represented the only region in the genome
at which clustering of older and younger SVA subfamilies overlapped (Figure 2b).
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highest number of SVAs. Red bars indicate regions with four or more SVA A, B, and Cs, while blue 
bars identify regions with six or more SVAs of the more recent D–F1 subfamilies. By overlaying SVA 
data for both older and younger SVA subclasses, we find that the chr19:20,000,000–24,000,000 locus 
is the only region in the genome at which clustering of both older and younger SVA classes is 
observed. This suggests sustained SVA-mediated evolution at this specific region on chromosome 19, 
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Figure 2. SVA elements preferentially cluster on chromosome 19. (a) Chromosome 19 is the only autosome
that displays no correlation between SVA and transcript number per megabase (correlation coefficient =
−0.055, Supplementary File 3). This apparent lack of correlation is skewed by a small number of regions
which are vastly over-represented for SVAs based on their gene density (red points). (b) Mapping SVA
density per megabase across the whole genome revealed regions with the highest number of SVAs. Red
bars indicate regions with four or more SVA A, B, and Cs, while blue bars identify regions with six or
more SVAs of the more recent D–F1 subfamilies. By overlaying SVA data for both older and younger SVA
subclas es, we find that the chr19:20,000,000–24,000,000 locus is the only regio in the genome at which
clustering of both older and younger SVA class s is bserved. This sugg sts sustained SVA-mediated
evolution at this specific region on chromosome 19, from the evolution of the earliest SVA class to more
recent human-specific changes. We further identify six regions that have high rates of SVA D–F1 subfamily
insertions, including three additional zinc finger loci on chromosomes 4, 7, and 19.
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Within this four megabase region, we identified 101 transcripts encoded by 47 genes, of which 32
(68.09%) were zinc finger genes (Figure 3a). Of the 32 zinc finger genes at this locus, 27 encoded zinc
finger proteins that contained a KRAB domain. This is of interest as the KRAB domain-containing class
of zinc finger proteins are known to bind and regulate the activity of retrotransposable elements [22].
Across this same region lay 41 SVAs (17 older SVAs, and 24 younger SVAs), which gave an average of
one SVA per 2.46 transcripts, or one SVA per 1.14 genes.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  6 of 19 
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reveals that SVA clustering in this area falls directly across a large zinc finger gene locus, with no 
SVAs in the regions flanking either side. Observation of the Multiz vertebrate genome alignment data 
demonstrated significant change around this zinc finger locus through primate evolution, in clear 
contrast to the strongly conserved flanking region to the left. The white region on the right of the 
Multiz alignment track shows the centromere of chromosome 19, an area with no available sequence 
data. (b) The ZNF91 gene resides in the chr19:20,000,000–24,000,000 SVA-rich zinc finger cluster 
(boxed in (a); chr19:23,464,801–23,613,281 shown in (b)), which is of interest due to its known role in 
suppressing SVA mobilisation. ZNF91 is a primate-specific gene and contains an SVA C and SVA D 
insertion in the third intron which may have influenced expression or splicing of this gene specific to 
primate species from gorillas through to humans. Further, we observe a second SVA C approximately 
24 kb upstream of the ZNF91 transcriptional start site, and an SVA B around 67 kb downstream of the 
3′ UTR. From these locations, all four SVAs have the potential to modulate ZNF91 expression through 
methods including binding transcription factors, altering local chromatin structure, or modulating 
splicing. 
Figure 3. SVAs on chromosome 19 cluster at a KR B ZNF zinc finger locus. (a) Visualisation of the
chr19:20,000,000–24,000,000 locus and flanking regions (chr19:19,000,000–25,000,000; GRCh37/hg19)
reveals that SVA clustering in this area falls directly across a large zinc finger gene locus, with no
SVAs in the regions flanking either side. Observation of the Multiz vertebrate genome alignment data
demonstrated significant change around this zinc finger locus through primate evolution, in clear
contrast to the strongly conserved flanking region to the left. The white region on the right of the Multiz
alignment track shows the centromere of chromosome 19, an area with no available sequence data. (b)
The ZNF91 gene resides in the chr19:20,000,000–24,000,000 SVA-rich zinc finger cluster (boxed in (a);
chr19:23,464,801–23,613,281 shown in (b)), which is of interest due to its known role in suppressing SVA
mobili ation. ZNF91 s a p imate-specific gene and contains an SVA C and SVA D insertion in the third
intron which may have influenced expression or splicing of thi gene specific to primate species from
gorillas through to humans. Further, we bserve a seco SVA C approximately 24 kb upstream of the
ZNF91 transcriptional start site, and an SVA B around 67 kb downstream of the 3′ UTR. From these
locations, all four SVAs have the potential to modulate ZNF91 expression through methods including
binding transcription factors, altering local chromatin structure, or modulating splicing.
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The second smaller region highlighted on chromosome 19 (Chr19:53,000,000–54,000,000) was
enriched only for the younger classes of SVAs (Figure 4a) and contained 33 genes (which encoded 100
transcripts), of which 25 (75.76%) were zinc finger genes of the ZNF family, with 20 of the 25 being
KRAB domain-containing zinc finger genes. This one megabase locus contained eight SVAs, with an
average of one SVA per 12.5 transcripts or per 4.13 genes. Of the remaining five loci at which clustering
of a high number of younger SVAs was seen (Supplementary File 2), two of these, at Chr4:1–1,000,000
and at Chr7:64,000,000–65,000,000 were also zinc finger gene cluster regions (Figure 4b, c). Our
data suggests a sustained drive for SVA-mediated evolution at the Chr19:20,000,000–24,000,000 locus
throughout primate evolution over the last 13.6 million years, and a more recent evolution uniquely in
higher primates, including chimpanzees and humans, involving multiple other zinc finger loci.
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Figure 4. Three of the remaining five regions enriched for reference SVA D–F1 insertions are zinc finger
clusters. In addition to the chr19:20,000,000–24,000,000 locus, three of the remaining five loci with the
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highest rates of SVA D–F1 insertions are at zinc finger regions. A second locus was identified
on chromosome 19 at chr19:53,000,000–54,000,000, and two separate loci at chr4:1–1,000,000 and
chr7:64,000,000–65,000,000 (expanded loci shown as chr19:51,812,498–55,187,502, chr4:1–2,250,000, and
chr7:63,000,000–66,000,000). (a) The chr19:53,000,000–54,000,000 locus contains one SVA A, four SVA
Ds, and three SVA Es, as well as 25 zinc finger genes. We observe the extension of this zinc finger
gene cluster outside of this specific megabase, with additional SVA Ds present at either end of the zinc
finger cluster. (b) A significantly smaller zinc finger gene cluster resides within the first megabase of
chromosome 4 (chr4:1–1,000,000), encompassing three SVA Ds, two SVA Es, and an SVA F, arranged
over a stretch of six zinc finger genes on the tip of the chromosome and into the remainder of this
megabase. We note that the two human-specific SVA Es are directly over a genome-wide associated
region for Parkinson’s disease (PD) encompassing the GAK and DGKQ genes, with one SVA E within a
GAK intron, and the second lying within 2 kb of the DGKQ transcriptional start site. SVAs at this region
could therefore modulate expression of both zinc finger and PD-related genes at this locus uniquely in
humans. (c) The final SVA-rich zinc finger gene cluster is identified at chr7:64,000,000–65,000,000 and
contains one SVA B, two SVA Cs, five SVA Ds, one SVA E, and two SVA Fs, spread across six zinc finger
genes. Expanding this locus shows four additional zinc finger genes adjacent to this megabase, with a
sixth SVA D.
Three of the zinc finger clusters shown to be targeted by SVA insertions in this study
(Chr19:20,000,000–24,000,000; Chr4:1–1,000,000; and Chr7:64,000,000–65,000,000) were part of the
primate-specific ZNF91 subfamily; a region which has been partially duplicated numerous times across
multiple chromosomes throughout primate evolution [26].
The ZNF91 protein is known to repress SVA mobilisation [22], which is of interest given its location
within the most SVA-dense region of the genome at the Chr19:20,000,000–24,000,000 locus. The region
around the ZNF91 gene has itself undergone SVA-mediated change, as was apparent from observation
of the Multiz vertebrate sequence alignments that showed gaps in primate species conservation where
SVAs have inserted at this locus. ZNF91 had two chimp- and human-specific SVAs of the C and D
classes within the third intron of the gene, an additional SVA C approximately 24 kb upstream of the
ZNF91 transcriptional start site, and an SVA B around 67 kb downstream of the 3′ UTR (Figure 3b). The
location of these SVAs may impact ZNF91 expression and splicing uniquely in higher primate species
such as common chimpanzees and humans. It has previously been suggested that ZNF91 underwent
rapid evolutionary change around 8 to 12 million years ago [22], which coincided with the evolution
and expansion of the SVA subfamilies B, C, and D, which are found at this gene, around 11.6, 10.9, and
9.6 million years ago [3].
In order to more clearly understand the increase in young SVA subfamilies at the above identified
1 Mb zinc finger loci, the number of elements from each SVA subfamily at these loci were compared
with SVA subfamily elements across the whole genome. Notable differences were identified as seen in
Figure 5. Across the entire genome, older SVA subfamilies SVA A–C comprise 34.44% of all SVAs, while
these subfamilies account for only 16.00% of SVAs identified at the 1 Mb zinc finger loci on chromosomes
4, 7, and 19 (0.46-fold change). This difference is predominantly driven by an under-representation of
the oldest SVA subtypes A and B at zinc finger loci, and a strong over-representation of the SVA E
subfamily. No SVA F1 elements were identified at the three zinc finger cluster regions used in this
analysis (chr4:1–1,000,000, chr7:64,000,000–65,000,000, chr19:53,000,000–54,000,000), and thus we were
not able to compare change in this subtype. Given that the SVA F1 subtype is the most recently evolved
SVA element, and is the smallest in number across the genome, their lack of representation at the three
zinc finger regions used in this analysis is perhaps not unexpected.
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demonstrated that 34. % of all SVAs were c ris f t e evolutionary older A–C subfamilies and
are therefore conserved at their respective loci within multiple primate speci s including humans. The
remaining 65.56% is comprised of younger subfamily memb rs D–F1. SVA D is by far the largest SVA
subfamily, co prising 44.39% of all SVA elements in the genome, s e of which are uman-specific,
with others being p esent in multiple primat species. 21.17% of SVAs (subfamilies E–F1) are entirely
human-specific. SVA B, F, and C each represent ove 10% of all SVAs, with a percentage of 16.45, 13.43,
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and 10.17%, respectively. The remaining subfamilies (SVA A, E, and F1) make up less than 10% of
the total each. (b) The percentage of each SVA subfamily at the 1 Mb SVA clustered ZNF loci on
chromosomes 4, 7, and 19 showed that older SVA subfamilies SVA A–C were reduced by 2.15-fold to
16.00% compared to the whole genome composition. This shift is due to an under-representation of
SVA A and B subtypes (0.51- and 0.24-fold change, respectively), and a strong 4.86-fold increase in the
SVA E subfamily = at the identified ZNF loci.
SVA A and B subfamilies were found to display a 0.51-fold and 0.24-fold change in occurrence at
the 1 Mb zinc finger loci compared to the genome-wide average, while the SVA D and F subfamilies
remained fairly constant with a 1.08 and 0.89-fold-fold change, respectively. On the other hand, the
SVA E subfamily was over-represented by 4.86-fold (Figure 5). This is of particular interest given
the increased GC content in human-specific SVA elements, and their increased potential to form
G-quadruplex structures (via the (CCCTCT)n hexamer repeat) that are known to modulate expression
of neighbouring genes [11,17,29,30]. The SVA F1 subfamily was not present in any of the three ZNF
loci in this analysis, but was over-represented at the 4 Mb loci on chromosome 19 compared to the
genome-wide average (chr19:20,000,000–24,000,000; 3.15-fold change). Damert et al. have hypothesised
that the 5′ transduction of the GC-rich MAST2 exon 1, which has been incorporated into the SVA F1
structure, may confer an advantage to this SVA subfamily leading to increased copy number in the
genome [31,32].
Work by Imbeault et al. used ChIP-exo (a high resolution modification of ChIP-seq) to profile the
binding enrichment of 159 zinc finger proteins (ZFPs) across a wide range of different transposable
elements [33]. We made use of this publicly available data set to assess KRAB-ZFPs that demonstrated
significant binding enrichment at SVA elements. Of the 159 proteins profiled, 15 showed a significant
enrichment for binding at one or more SVA subfamilies using the p-value cut-off of 1 × 10−20 (Table 1).
Six of these 15 proteins (40%) were within the previously identified SVA-dense regions. Strikingly,
we find that zinc finger proteins that are enriched for binding the older SVA subfamilies (SVA A–C)
reside exclusively within regions identified as over-represented for SVAs in our above analysis. On
the other hand, the nine ZFPs outside of SVA-dense regions that are enriched for SVA binding only
demonstrate significance for their enrichment at younger SVA subfamily elements (SVA D–F). Notably,
ZNF611 (residing within the chr19:53,000,000–54,000,000 locus) displays highly significant enrichment
for binding across all SVA subfamilies, with a p-value of 1.14 × 10−320 for enrichment at SVA A–D and
F elements, and 7.8 × 10−200 at SVA E elements.
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Table 1. Publicly available KRAB-zinc finger protein (ZFP) binding enrichment data from ChIP-exo studies by Imbeault et al. [33]. Fifteen ZFPs were found to be
significantly enriched for binding one or more SVA subfamilies at the p-value cut-off of 1 × 10−20. Six such ZFPs were located at regions found to be over-represented
for SVAs. Notably, ZFPs displaying enrichment for older SVA subfamilies (SVA A–C) were only found within SVA-rich zinc finger loci.
Protein Position SVA Locus
Binding Enrichment (p-Value)
SVA A SVA B SVA C SVA D SVA E SVA F
ZNF141 chr4:331,596–367,691 Y 7.76 × 10−6 4.53 × 10−89 1.04 × 10−62 5.07 × 10−5 0.13 0.40
ZNF736 chr7:63,773,186–63,810,017 Y 0.61 1.00 0.53 3.13 × 10−14 3.98 × 10−4 1.24 × 10−23
ZNF257 chr19:22,235,266–22,273,903 Y 4.43 × 10−83 4.11 × 10−10 4.85 × 10−4 2.11 × 10−6 0.19 4.9 × 10−5
ZNF730 chr19:23,299,777–23,330,017 Y 1.00 1.00 0.17 2.97 × 10−27 6.05 × 10−7 3.99 × 10−42
ZNF611 chr19:53,206,066–53,238,307 Y 1.14 × 10−320 1.14 × 10−320 1.14 × 10−320 1.14 × 10−320 7.8 × 10−200 1.14 × 10−320
ZNF28 chr19:53,300,661–53,324,922 Y 1.09 × 10−67 1.09 × 10−22 4.62 × 10−25 2.5 × 10−234 3.37 × 10−4 3.2 × 10−110
ZKSCAN5 chr7:99,102,273–99,131,445 N 2.93 × 10−13 9.43 × 10−5 8.21 × 10−3 2.6 × 10−39 2.77 × 10−31 1.92 × 10−74
ZNF202 chr11:123,594,997–123,612,363 N 0.91 0.88 0.73 2.52 × 10−12 2.04 × 10−13 7.67 × 10−57
ZNF641 chr12:48,733,793–48,744,674 N 0.01 1.71 × 10−5 3.79 × 10−13 2.7 × 10−201 4.1 × 10−104 2.4 × 10−304
ZNF605 chr12:133,498,019–133,532,892 N 7.96 × 10−3 0.07 0.04 7.83 × 10−58 1.03 × 10−23 4.68 × 10−67
ZNF558 chr19:8,920,382–8,933,565 N 0.05 1.00 1.69 × 10−4 8.94 × 10−57 1.55 × 10−30 6.4 × 10−135
ZNF30 chr19:35,417,807–35,436,076 N 1.00 0.14 2.22 × 10−4 2.56 × 10−63 5.32 × 10−28 2.5 × 10−134
ZNF780A chr19:40,578,899–40,596,845 N 0.25 3.70 × 10−3 1.79 × 10−3 1.14 × 10−26 0.02 2.59 × 10−14
ZNF649 chr19:52,392,488–52,408,305 N 1.87 × 10−3 0.06 7.23 × 10−6 6.1 × 10−158 9.68 × 10−66 3.9 × 10−191
ZNF334 chr20:45,128,269–45,142,198 N 1.00 0.05 1.00 2.1 × 10−12 2.91 × 10−17 2.14 × 10−21
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2.2. Analysis of Human Retrotransposon Insertion Polymorphisms Suggests Continued Evolution of Zinc
Finger Loci
SVAs remain mobile in the human genome, with recent studies suggesting multiple new and
unique somatic insertions in the brain of each individual [34–36], as well as numerous unique germline
insertions [37–39]. In order to extend this study to cover the patterns of continued SVA-mediated
diversity in modern humans, we made use of the TEBreak tool (https://github.com/adamewing/tebreak)
which contained a list of known and predicted germline SVA retrotransposon insertion presence/absence
polymorphisms (RIPs), and repeated the above analysis for such RIPs across the genome per megabase
(Supplementary File 2).
The list from TEBreak identified 1148 SVA RIPs, and distribution analysis demonstrated that
these RIPs follow the same general trend as reference SVAs, with a positive correlation between
transcript number and SVA RIP number (correlation coefficient = 0.31; Figure 6; Supplementary
File 3). Distribution analysis revealed three loci with the highest rate of polymorphic SVA insertion,
with five identified SVA RIPs each at Chr1:28,000,001–29,000,000, chr9:134,000,001–135,000,000, and
Chr19:44,000,001–45,000,000. Of these three, the Chr19:44,000,001–45,000,000 locus was found to be
another zinc finger cluster (Figure 7). This region had three reference SVAs and was therefore not
considered to be over-represented for reference SVA insertions. This may suggest SVA-mediated
evolution at a further zinc finger locus which is ongoing in modern humans.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  2 of 19 
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undergo genomic change which may modulate the expression of genes at this locus uniquely in modern
humans, and differently between individuals based on the presence or absence of these insertions.
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3. Discussion
Our finding that human reference genome SVAs cluster primarily at zinc finger loci on
chromosome 19 is in line with previous observations that this chromosome is enriched for
transposable elements [3,12,13], and particularly that zinc finger gene clusters on this chromosome are
over-represented for other transposable element classes such as ERVs and LTRs [27,28]. Taking a more
detailed view across the genome by megabase highlighted an over-representation of SVAs at zinc finger
gene clusters, both at multiple sites across chromosome 19, and additionally on chromosomes 4 and 7.
We demonstrate that, outside of the Chr19:20,000,000–24,000,000 locus, this pattern largely involves
younger SVA subfamilies, and observe suggestive evidence that this process may be ongoing in
humans, with the distribution of polymorphic SVA insertions highlighting an additional chromosome
19 zinc finger locus with a high density of SVA RIPs. Taken together, these data may suggest that the
movement of SVA subfamilies across higher primate and human genomes could have impacted a broad
range of transcriptional networks through SVA targeting of zinc finger gene clusters. KRAB ZNFs
and SVAs are known to have co-evolved, with the evolution and expansion of new SVA subfamilies
across the genome prompting multiple rounds of zinc finger gene evolution in order to continue
repressing the mobilisation of newly evolving SVA classes [22]. ZNF proteins have been shown to
bind fragments of retrotransposon sequence and use these as platforms for the regulation of nearby
genes [33]. In SVAs, the VNTR region was shown to be sufficient for ZNF91 binding and repression
of SVA mobilisation [22]. It is known that ZNFs repress retrotransposons through the recruitment of
TRIM28 and subsequent alteration of histone modifications. Studies of TRIM28-mediated repression of
transposable elements, such as endogenous retroviruses, has demonstrated that histone modification
at these elements affects local chromatin structure and regulation of neighbouring genes [40,41]. The
over-representation of younger SVA subfamilies at the zinc finger loci identified here is also of interest
due to the increased ability to regulate nearby gene expression. This heightened regulatory capacity of
recently evolved SVA subfamilies is due to increased VNTR length and higher GC content, with the
latter potentially forming the regulatory G-quadruplex DNA structure [11,17,31,32].
Given that zinc fingers are the largest class of transcription factors in the human genome [23,42],
any SVA-mediated effects on their regulation could have the potential for wide-ranging transcriptional
and epigenetic consequences. Data from the Geneotype-Tissue Expression project (GTEx; https:
//gtexportal.org) highlights many eQTLs residing in SVA sequences which are thought to be associated
with zinc finger expression across a wide range of tissues. While interesting, it is difficult to disentangle
linkage disequilibrium to identify the SNPs with truly causal effects on gene expression. However,
such efforts may be of interest with regard to directing future research in this area. Further to this,
work by Imbeault et al. identified 15 KRAB-ZFPs that are significantly enriched for binding at SVA
elements. Six such ZFPs reside within the above identified SVA-dense loci, and intriguingly, ZFPs that
bind older SVA subfamilies (SVA A–C) are restricted to these SVA-dense genomic loci (Table 1).
The process of retrotransposon mobilisation is ongoing in humans, and has been demonstrated to
have impacts both in human health and disease. For example, X-Linked Dystonia-Parkinsonism (XDP),
is a progressive neurodegenerative condition which is thought to be caused by a polymorphic SVA
insertion in the 32nd intron of the TAF1 gene [43]. Variation in the repeat length of the (CCCTCT)n
domain of this SVA in those with XDP has been significantly correlated with age of onset, symptom
severity, and expression of the TAF1 gene in patient blood samples [44,45]. Further, a polymorphic SVA
E insertion within intron 8 of the CASP8 gene, tagged by the variant rs700635 (C), has been associated
with CASP8 splicing abnormalities, as well as increased risk of cutaneous basal cell carcinoma and
breast cancer [46,47]. On the other hand, the same SVA has been associated with protection against
prostate cancer [47], suggesting that such polymorphic insertions could play a variety of roles with
regard to variation in human health and disease.
We identified 1148 polymorphic SVA insertions in the human population, which are present or
absent in the genome, and demonstrated that these elements followed similar insertion patterns to
their reference genome counterparts. SVA RIPs were found at increased levels in genic regions, and
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particularly at an additional zinc finger gene locus on chromosome 19, suggesting the potential for
continued SVA-mediated evolution of zinc finger gene loci in humans.
Taken together, we observe that SVAs have continually inserted and been retained at ZNF loci,
and may be continuing to do so in modern human populations. Work by Jacobs et al. has provided
evidence of SVA and zinc finger co-evolution [22], thereby supplying one potential mechanism driving
retrotransposon-mediated evolution of this large class of transcription factors in higher primates and
humans. SVAs are known to be bound by a number of KRAB zinc finger proteins [33], as well as
regulators of chromatin architecture including CTCF and CTCFL [48]. Such retrotransposon-mediated
changes in genomic structure may therefore play a role in the 3D organisation of chromatin, with
the potential to affect gene expression patterns more globally, though future research efforts will be
required in order to test this hypothesis.
4. Methods
4.1. Co-Ordinates of Reference Genome and Insertion Polymorphism SVA Elements
Annotations for reference genome SVA elements were accessed through the UCSC table browser
using the ‘repeat masker’ track from human genome build 19 (GRCh37/hg19), and were subsequently
corrected for overlapping or split reads.
The list of retrotransposon insertion polymorphisms was compiled by Adam Ewing and is available
through the TEBreak programme, which characterises non-reference retrotransposon insertions (https:
//github.com/adamewing/tebreak). This list was compiled using known or predicted non-reference
germline insertions found in multiple studies assessing RIPs in humans [37–39,49–51].
4.2. Transcript Data and SVA Distribution Analysis
The number of retrotransposon insertions per megabase was counted using custom scripts
written in R, and the number of transcripts per megabase was accessed through R using the
‘TxDb.Hsapiens.UCSC.hg19.knownGene’ library via a script written by Dr. Giovanni M Dall’Olio and
published through the BioStars website (https://www.biostars.org/p/169171/#169211).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/23/5977/
s1. Supplementary File 1—Excel spreadsheet detailing the co-ordinates of all SVA elements in the human reference
genome (hg19). Supplementary File 2—Excel spreadsheet detailing the number transcripts, reference genome SVAs,
and SVA insertion polymorphisms (RIPs) per megabase of the human genome (hg19). Supplementary File 3—Excel
spreadsheet of correlation coefficients for transcript number and SVA number for each human chromosome.
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